Cooper Companies Inc
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.09B | $3.59B | $3.39B | $3.31B | $2.92B | $2.43B | $2.65B | $2.53B |
| CooperVision | — | $2.42B | $2.24B | $2.25B | $1.95B | $1.71B | $1.93B | $1.85B |
| CooperSurgical | — | $1.16B | $1.15B | $1.06B | $974.3M | $719.1M | $725.2M | $682.8M |
| Cost of Revenue | $1.41B | $1.30B | $1.24B | $1.17B | $966.7M | $896.1M | $896.6M | $900.5M |
| Gross Profit | $2.68B | $2.60B | $2.36B | $2.14B | $1.96B | $1.53B | $1.76B | $1.63B |
| Gross Margin | 65.5% | 72.4% | 69.5% | 64.7% | 66.9% | 63.1% | 66.2% | 64.4% |
| Operating Expenses | ||||||||
| Research & Development | $172.2M | $155.1M | $137.4M | $110.3M | $92.7M | $93.3M | $86.7M | $84.8M |
| SG&A Expense | $1.63B | $1.53B | $1.50B | $1.34B | $1.21B | $992.5M | $996.2M | $973.3M |
| Operating Income | $682.9M | $705.7M | $533.1M | $507.6M | $505.8M | $311.8M | $546.7M | $403.1M |
| Operating Margin | 16.7% | 19.7% | 15.7% | 15.3% | 17.3% | 12.8% | 20.6% | 15.9% |
| Interest Expense | — | — | $105.3M | $57.3M | $23.1M | $36.8M | $68.0M | $82.7M |
| Pretax Income | $566.5M | $582.3M | $412.9M | $475.3M | $491.5M | $266.5M | $477.4M | $331.9M |
| Income Tax Expense | $191.6M | $190.0M | $118.7M | $89.5M | $-2.45B | $28.1M | $10.7M | $192.0M |
| Net Income | $374.9M | $392.3M | $294.2M | $385.8M | $2.94B | $238.4M | $466.7M | $139.9M |
| Net Margin | 9.2% | 10.9% | 8.7% | 11.7% | 100.8% | 9.8% | 17.6% | 5.5% |
| EPS (Basic) | $1.88 | $1.97 | $1.49 | $1.95 | $14.95 | $1.21 | $2.36 | $0.71 |
| EPS (Diluted) | $1.87 | $1.96 | $1.48 | $1.94 | $14.79 | $1.20 | $2.33 | $0.70 |
| Shares Outstanding (Basic) | 199.1M | 198.9M | 197.9M | 197.4M | 196.8M | 196.4M | 197.6M | 196.4M |
| Shares Outstanding (Diluted) | 200.0M | 200.4M | 199.3M | 198.8M | 199.2M | 198.4M | 200.0M | 198.8M |
| Dividends Per Share | — | — | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |